Journal
EXPERIMENTAL NEUROBIOLOGY
Volume 28, Issue 5, Pages 547-553Publisher
KOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE
DOI: 10.5607/en.2019.28.5.547
Keywords
Neuroinflammation; alpha-synudein; Toll-like receptor 2; Immunotherapy; Synudeinopathy
Categories
Funding
- Intramural research Program of the National Institutes of Health, National institute on Aging
Ask authors/readers for more resources
Synudeinopalhies are neurodegeneralive disorders characterized by the progressive accumulation of alpha-synuclein (alpha-syn) in neurons and glia and include Parkinson disease (PD) and dementia with Lewy bodies (DLB). In this review, we consolidate our key findings and recent studies concerning the role of Toll-like receptor 2 (TLR2), a pattern recognition innate immune receptor, in the pathogenesis of synucleinopathies. First, we address the pathological interaction of alpha-syn with microglial TLR2 and its neurotoxic inflammatory effects. Then, we show that neuronal TLR2 activation not only induces abnormal a-syn accumulation by impairing autophagy but also modulates alpha-syn transmission. Finally, we demonstrate that administration of a TLR2 functional inhibitor improves the neuropathology and behavioral deficits of a synucleinopathy mouse model. Altogether, we present TLR2 modulation as a promising immunotherapy for synucleinopathies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available